Compare RCUS & BTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | BTE |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.3B |
| IPO Year | 2018 | 2004 |
| Metric | RCUS | BTE |
|---|---|---|
| Price | $24.23 | $5.17 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $31.90 | N/A |
| AVG Volume (30 Days) | 1.4M | ★ 13.7M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.62 | $7.93 |
| P/E Ratio | ★ N/A | $18.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.58 | $2.18 |
| 52 Week High | $31.74 | $5.36 |
| Indicator | RCUS | BTE |
|---|---|---|
| Relative Strength Index (RSI) | 25.83 | 63.34 |
| Support Level | $23.91 | $3.96 |
| Resistance Level | $24.33 | $5.17 |
| Average True Range (ATR) | 1.31 | 0.15 |
| MACD | -0.71 | 0.00 |
| Stochastic Oscillator | 0.66 | 84.00 |
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.